financetom
Business
financetom
/
Business
/
John B. Sanfilippo & Son's Fiscal Q3 Earnings Decline, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
John B. Sanfilippo & Son's Fiscal Q3 Earnings Decline, Revenue Increases
May 2, 2024 2:07 AM

04:49 AM EDT, 05/02/2024 (MT Newswires) -- John B. Sanfilippo & Son ( JBSS ) reported fiscal Q3 earnings Wednesday of $1.15 per diluted share, down from $1.35 a year earlier.

Revenue for the quarter ended March 28 was $271.9 million, compared with $238.5 million a year earlier.

Analysts' estimates were not readily available for comparison.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. Global Investors Q1 net income jumps 378% helped by investment income gains
U.S. Global Investors Q1 net income jumps 378% helped by investment income gains
Nov 12, 2025
Overview * U.S. Global Investors ( GROW ) fiscal Q1 net income rises 378% yr/yr, driven by investment income * Company fiscal Q1 operating revenues up 15% from June qtr, 4% yr/yr * Fund flows into gold mining and natural resource funds turn positive Result Drivers * INVESTMENT INCOME - Net income increase largely driven by investment income, which rose...
Lyell Immunopharma Q3 adjusted net loss beats estimates
Lyell Immunopharma Q3 adjusted net loss beats estimates
Nov 12, 2025
Overview * Lyell Q3 adjusted net loss beats analyst expectations * Company acquired global rights to LYL273, a GCC-targeted CAR T-cell product * Initiated PiNACLE - H2H Phase 3 trial for aggressive large B-cell lymphoma Outlook * Company expects to begin PiNACLE - H2H trial enrollment by early 2026 * Lyell anticipates LYL273 Phase 1 trial data update in H1...
GRAIL Q3 Loss Narrows, Revenue Rises
GRAIL Q3 Loss Narrows, Revenue Rises
Nov 12, 2025
04:33 PM EST, 11/12/2025 (MT Newswires) -- GRAIL (GRAL) reported a Q3 net loss late Wednesday of $2.46 per diluted share, narrowing from the loss of $3.94 a year earlier. Four analysts polled by FactSet expected a loss of $3.37. Revenue in the three months ended Sept. 30 rose to $36.2 million from $28.7 million a year earlier. Three analysts...
Crescent Capital's Q3 NAV per share falls
Crescent Capital's Q3 NAV per share falls
Nov 12, 2025
Overview * Crescent Capital BDC ( CCAP ) Q3 net investment income per share was $0.46, unchanged from Q2 * Net asset value per share declines to $19.28 from $20.20 year-over-year * Company declares Q4 regular cash dividend of $0.42 per share Outlook * Company has $239.8 mln undrawn capacity on credit facilities * Weighted average cost of debt is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved